Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Mengqi Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buff…. Hauptthemen laut MEDLINE: Dronabinol, Cytochrome P-450 Enzyme System, Cytochrome P-450 Enzyme Inhibitors, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
The increased use of cannabis in many parts of the United States and other countries has led to a need for a more comprehensive understanding of cannabis constituents and their potential for drug-drug interactions. Δ8-Tetrahydrocannabinol (Δ8-THC) is a psychoactive cannabinoid that is found at low concentrations in cannabis but is growing in popularity, especially where the use of Δ9-THC is restricted. Although certain cannabinoids including cannabidiol (CBD) are known to inhibit several metabolizing enzymes including many in the cytochrome P450 family, the effects of Δ8-THC remain poorly characterized. This study evaluated the inhibitory potential of Δ8-THC and its metabolites, 11-hydroxy-Δ8-THC and 11-nor-Δ8-THC-9-carboxylic acid, on major hepatic cytochrome P450 enzymes using in vitro assays with recombinant P450-overexpressing microsomes and pooled human liver microsomes. Δ8-THC and 11-hydroxy-Δ8-THC significantly inhibited CYP2C9- and CYP3A4-mediated metabolism in a dose-dependent, reversible manner. Lineweaver-Burk analysis indicated competitive inhibition for CYP2C9-mediated warfarin hydroxylation and noncompetitive inhibition for CYP2C9- and CYP3A4-mediated metabolism of diclofenac and midazolam, respectively. In contrast, 11-nor-Δ8-THC-9-carboxylic acid showed no significant inhibition of P450 enzymes. Static modeling predicted clinically relevant drug interactions, particularly with oral Δ8-THC. These findings underscore the potential for Δ8-THC to impact the pharmacokinetics of coadministered drugs and highlight the need for further clinical studies. SIGNIFICANCE STATEMENT: This study is the first to assess how Δ8-tetrahydrocannabinol and its active metabolites inhibit key hepatic P450 enzymes. Results suggest a high risk of Δ8-tetrahydrocannabinol-related drug interactions, especially with oral use, underscoring the need for clinical caution and further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York.
- Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington.
- Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York. Electronic address: plazarus@buffalo.edu.
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
- State of Washington
Zitieren
APA
Zhao, M., Coates, S., Bardhi, K., & Lazarus, P. (2025). Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100122
Vancouver
Zhao M, Coates S, Bardhi K, Lazarus P. Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100122
BibTeX
@article{Zhao2025,
author = {Zhao, Mengqi and Coates, Shelby and Bardhi, Keti and Lazarus, Philip},
title = {Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100122}
}
EUVIMED